Personal information

Activities

Employment (6)

The University of Manchester: Manchester, GB

Employment
Source: check_circle
University of Manchester - PURE

University of Manchester: Manchester, Greater Manchester, GB

2018-08-01 to present | Reader in Neuroscience (Department of Neuroscience and Experimental Psychology)
Employment
Source: Self-asserted source
Emmanuel Pinteaux

University of Manchester - Faculty of Life Sciences: Manchester, Manchester, GB

2013-08-01 to 2018-07-31 | Senior Lecturer
Employment
Source: Self-asserted source
Emmanuel Pinteaux

University of Manchester - Faculty of Life Sciences: Manchester, Manchester, GB

2007-08-01 to 2013-07-31 | Lecturer
Employment
Source: Self-asserted source
Emmanuel Pinteaux

University of Manchester Faculty of Life Sciences: Manchester, Manchester, GB

2006-08-01 to 2007-07-31 | Research Fellow
Employment
Source: Self-asserted source
Emmanuel Pinteaux

University of Manchester Faculty of Life Sciences: Manchester, Manchester, GB

1998-10-01 to 2006-07-31 | Post Doctoral Research Associate
Employment
Source: Self-asserted source
Emmanuel Pinteaux

Education and qualifications (3)

Université de Strasbourg - Faculté des sciences de la Vie: Strasbourg, FR

1994-07 to 1997-11 | PhD Cellular and Molecular Neurobiology
Education
Source: Self-asserted source
Emmanuel Pinteaux

Université de Strasbourg - Faculté des sciences de la vie: Strasbourg, FR

1993-09 to 1994-06 | MRes Cellular and Molecular Biology, Distinction
Education
Source: Self-asserted source
Emmanuel Pinteaux

Université Louis Pasteur - Faculté des Sciences de la Vie: Strasbourg, FR

1988-09-01 to 1992-06-31 | BSc Biochemistry (2.I Honours)
Education
Source: Self-asserted source
Emmanuel Pinteaux

Funding (10)

Understanding the specific role of IL-1alpha and IL-1beta during post-stroke cerebrovascular inflammation

2022-09-01 to 2024-08-31 | Grant
British Heart Foundation (London, GB)
GRANT_NUMBER: PG/21/10730
Source: Self-asserted source
Emmanuel Pinteaux via DimensionsWizard

Interleukin-1 alpha as a novel treatment for ischemic stroke

2018-07-01 to 2023-05-31 | Grant
National Institute of Neurological Disorders and Stroke (Bethesda, US)
GRANT_NUMBER: R01NS101752
Source: Self-asserted source
Emmanuel Pinteaux via DimensionsWizard

Mesenchymal stem cells preconditioning as therapeutic tool to promote recovery from stroke

Source: Self-asserted source
Emmanuel Pinteaux via DimensionsWizard

The role of extracellular matrix laminin-10 in vascular inflammation, blood-brain barrier repair and angiogenesis after cerebrovascular disease

Use of IL-1alpha to Promote Angiogenesis and Functional Recovery After Experimental Stroke

2014-07-01 to 2016-06-30 | Grant
National Institute of Neurological Disorders and Stroke (Bethesda, US)
GRANT_NUMBER: 1R21NS085660-01A1
GRANT_NUMBER: 1R21NS085660-01A1
Source: Self-asserted source
Emmanuel Pinteaux
grade
Preferred source (of 2)‎

Can mesenchymal stem cells be primed to promote stroke recovery

2014-05 to 2016-04 | Grant
Stroke Association (London, GB)
GRANT_NUMBER:

TSA 2013-07

Source: Self-asserted source
Emmanuel Pinteaux

Vessel wall interleukin 1 drives inflammatory mechanisms in experimental atherosclerosis

2013-11 to 2016-10 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Emmanuel Pinteaux

Peripheral interleukin-1 as a target in cerebrovascular disease

2013-10 to 2016-09 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Emmanuel Pinteaux

Mechanisms of interleukin-1 action in neuronal injury

Source: Self-asserted source
Emmanuel Pinteaux via DimensionsWizard
grade
Preferred source (of 3)‎

The role of the acute phase protein pentraxin-3 in vascular inflammation and angiogenesis after cerebrovascular disease

Source: Self-asserted source
Emmanuel Pinteaux via DimensionsWizard
grade
Preferred source (of 2)‎

Peer review (10 reviews for 7 publications/grants)

Review activity for Advanced functional materials. (1)
Review activity for Advanced healthcare materials (2)
Review activity for Advanced materials. (1)
Review activity for Advanced science. (2)
Review activity for Advanced therapeutics. (2)
Review activity for APL bioengineering. (1)
Review activity for Journal of neuroinflammation (1)